![Alexander Meier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alexander Meier is the founder of MONDOSANO GmbH.
He currently works as a Director at Genui GmbH since 2017.
Aktive Positionen von Alexander Meier
| Unternehmen | Position | Beginn |
|---|---|---|
Genui GmbH
 Genui GmbH Investment ManagersFinance GENUI is an active manager which provides financing for buyouts, successions, growth capital requirements, as well as P2P (public to private) transactions. The firm invests in mid-sized companies located in German-speaking countries. It targets companies operating in various sectors and industries including retail/e-commerce, FinTech, logistics, and pharmaceuticals. | Private Equity Investor | 01.09.2017 |
Ehemalige bekannte Positionen von Alexander Meier
| Unternehmen | Position | Ende |
|---|---|---|
MONDOSANO GmbH
 MONDOSANO GmbH Internet Software/ServicesTechnology Services Operates an Internet platform, which provides users access to clinical research and new therapies | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Genui GmbH
Genui GmbH Investment ManagersFinance GENUI is an active manager which provides financing for buyouts, successions, growth capital requirements, as well as P2P (public to private) transactions. The firm invests in mid-sized companies located in German-speaking countries. It targets companies operating in various sectors and industries including retail/e-commerce, FinTech, logistics, and pharmaceuticals. | Finance |
MONDOSANO GmbH
MONDOSANO GmbH Internet Software/ServicesTechnology Services Operates an Internet platform, which provides users access to clinical research and new therapies | Technology Services |
